Main > A2. TRADEMARK. INDEX. R-Rm > Retaane

Product USA. A

GENERIC NAME This data is not available for free
MARKETING - Australia: Approved
- EU: Co. Withdrew Market Application
- USA: FDA Issued "Approvable Letter"
STRUCTURE 4,9(11)-Pregnadien-17.alpha.,21-diol-3,20-dione-21-acetate
INDICATION'S This data is not available for free
STATUS US Patent Expiration Date: 08.27.2017
THERAPEUTIC CLASS Angiostatic Steroids>Cortisol Acetate Analog
UPDATE 03.06.2008
COMPANY This data is not available for free
PATENT NUMBER This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back